Loading company…
Riskpilot
← Back to search
Sign in
Get full access
NUCLEAR PHARMA DISTRIBUTION AS
AS
Active
Org 917077649
Nordeidstølen 7, 5251 Søreidgrend
Engroshandel med spesialisert utvalg av nærings- og nytelsesmidler ikke nevnt annet sted · NACE 46389
Est. 2016
0 employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2020
NOK 5K
-94% vs 2019
EBITDA margin
-698.5%
-107% vs 2019
Equity ratio
-265.2%
Financial strength
Net profit 2020
NOK -35K
-103% vs 2019
EBITDA — year on year
NOK millions
0M
0M
1M
1M
1M
0M
2016
0M
0%
2017
0M
0%
2018
0M
0%
2019
0M
0%
2020
Key figures
Annual report 2020
Revenue
NOK 5K
-94%
EBITDA
NOK -35K
-107%
Net profit
NOK -35K
-103%
Total assets
NOK 50K
-44%
Equity
NOK -134K
-35%
Employees
0
—
Company information
Legal name
NUCLEAR PHARMA DISTRIBUTION AS
Org number
917077649
Legal form
Aksjeselskap
NACE code
46389 · Engroshandel med spesialisert utvalg av nærings- og nytelsesmidler ikke nevnt annet sted
Founded
21. april 2016
Share capital
NOK 3 000 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2020-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Kjøp, salg og formidling, samt merkevarebygging - nasjonalt og internasjonalt - av kosttilskudd og sunnhetsprodukter.
Contact
Address
Nordeidstølen 7, 5251 Søreidgrend
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Engroshandel med spesialisert utvalg av nærings- og nytelsesmidler ikke nevnt annet sted
Companies in Bergen
All Norway companies
Revenue
NOK millions
0M
0M
1M
1M
1M
0M
2016
0M
2017
0M
2018
0M
2019
0M
2020
EBITDA
NOK millions
0M
0M
1M
1M
1M
0M
2016
0M
2017
0M
2018
0M
2019
0M
2020
Income statement
NOK thousands
Item
2016
2017
2018
2019
2020
Revenue
108
75
50
85
5
Staff expenses
−0
−0
−0
−0
−0
EBITDA
−81
−51
−51
−17
−35
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
−81
−51
−51
−17
−35
Net financials
−7
−10
0
−0
0
Profit before tax
−87
−61
−50
−17
−35
Tax
−0
−0
−0
−0
−0
Net profit
−87
−61
−50
−17
−35
Balance sheet
NOK thousands
Item
2016
2017
2018
2019
2020
Total assets
411
266
128
91
50
Equity
30
−31
−82
−99
−134
Long-term debt
375
297
197
167
167
Short-term debt
7
0
13
22
17
Total debt
381
297
210
190
184
Financial ratios
5-year trend
EBITDA margin
-698.5%
This company
15.8%
Market median
-4521% vs market
2016
2020
Equity ratio
-265.2%
This company
38.2%
Market median
-794% vs market
2016
2020
Return on equity
-3491900.0%
This company
18.4%
Market median
-18977817% vs market
2016
2020
Net profit margin
-698.4%
This company
8.1%
Market median
-8722% vs market
2016
2020
Asset turnover
0.10×
This company
1.12×
Market median
-91% vs market
2016
2020
Debt / equity
1.38×
This company
0.62×
Market median
-123% vs market
2016
2020
Annual reports & filings
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
View
PDF
Annual report 2019
Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
View
PDF
Annual report 2018
Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
View
PDF
Annual report 2017
Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
View
PDF
Annual report 2016
Filed via Brønnøysundsregistrene · Period 2016-03-07 – 2016-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Age
Other directorships
MA
Marcus Andreas Olsen
Chairman
2016
—
—
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of NUCLEAR PHARMA DISTRIBUTION AS also hold positions in
0
other companies.
Person
Role here
Other companies
Marcus Andreas Olsen
Chairman
0 companies